MS CONTIN® (morphine sulfate controlled-release) Tablets, for oral use CII Initial U.S. Approval: 1941. WARNING: ABUSE POTENTIAL, LIFE-THREATENING RESPIRATORY DEPRESSION, and ACCIDENTAL EXPOSURE. See full prescribing information for complete boxed warning. MS CONTIN contains morphine sulfate, a Schedule II …